Please use this identifier to cite or link to this item:
http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/13893
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vasyuk, V.L. | - |
dc.contributor.author | Ilashchuk, T.O. | - |
dc.date.accessioned | 2018-06-13T08:52:34Z | - |
dc.date.available | 2018-06-13T08:52:34Z | - |
dc.date.issued | 2015 | - |
dc.identifier.other | УДК 616.361-089:570.8-002:615.24 | - |
dc.identifier.uri | http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/13893 | - |
dc.description.abstract | Aim of investigation is to determine the liver condition of rats with experimental immunodeficiency. Immune deficiency (ID) in rats was induced by the injection of the cytostatic cyclophosphamide. The presence of ID was determined by lymphocytes levels (in the blood) and lysocyme (in the serum and liver). The presence of hepatitis was identified by the levels of biochemical markers of liver inflammation (MDA, elastase) and cholestasis (ALP) as well as by the level of "liver markers" (ALT, bilirubin, alkaline phosphatase - ALP) in serum. Cyclophosphamide reduces the lymphocyte and lysocyme levels, and increases hepatic levels of inflammatory markers and cholestasis, and serum levels of "liver markers". Cyclophosphamide causes the development of immunodeficiency and hepatitis. | ru_RU |
dc.language.iso | en | ru_RU |
dc.publisher | Клінічна та експериментальна патологія | ru_RU |
dc.subject | immunodeficiency | ru_RU |
dc.subject | liver | ru_RU |
dc.subject | hepatitis | ru_RU |
dc.subject | enzymes | ru_RU |
dc.subject | імунодефіцит | ru_RU |
dc.subject | печінка | ru_RU |
dc.subject | гепатит | ru_RU |
dc.subject | ферменти | ru_RU |
dc.subject | иммунодефицит | ru_RU |
dc.subject | печень | ru_RU |
dc.subject | гепатит | ru_RU |
dc.subject | ферменты | ru_RU |
dc.title | Condition of rat' liver with experimental immunodeficiency | ru_RU |
dc.type | Article | ru_RU |
Appears in Collections: | Статті. Кафедра пропедевтики внутрішніх хвороб |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.